Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity

Bioorg Med Chem Lett. 2004 May 17;14(10):2473-6. doi: 10.1016/j.bmcl.2004.03.005.

Abstract

A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide, hydrazide, urea and 1-hydroxyprop-1-en-3-one moiety. Amide derivatives are the most promising ones and could serve as leads for further developments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Cross-Linking Reagents
  • HIV Infections / drug therapy
  • HIV Integrase / drug effects
  • HIV Integrase Inhibitors / chemical synthesis*
  • HIV Integrase Inhibitors / pharmacology
  • Humans
  • Inhibitory Concentration 50
  • Quinolines / chemical synthesis
  • Quinolines / pharmacology*
  • Structure-Activity Relationship
  • Virion / drug effects

Substances

  • Cross-Linking Reagents
  • HIV Integrase Inhibitors
  • Quinolines
  • HIV Integrase